SciSparc (SPRC) Exchange Rate Effect (2016 - 2018)
SciSparc (SPRC) posted Exchange Rate Effect of $600000.0 for Q4 2018, up 198.85% sequentially from -$607000.0 in Q3 2018, and up 470.37% YoY from $105194.8 in Q4 2017.
SciSparc (SPRC) Exchange Rate Effect (2016 - 2018) Analysis & Trends
SciSparc has reported Exchange Rate Effect for 3 years, with the latest figure at $600000.0 in Q4 2018.
- Quarterly Exchange Rate Effect rose 470.37% year-over-year to $600000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $301000.0 (up 157.12% YoY) and the FY2019 annual result came in at $9000.0, down 97.01% from the prior year.
- Exchange Rate Effect advanced to $600000.0 in Q4 2018 per SPRC's latest filing, from -$607000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $600000.0 in Q4 2018 and troughed at -$607000.0 in Q3 2018.
- A 3-year average of -$23400.0 and a median of $12000.0 in 2016 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 1185.71% in 2018, down 849.38% in 2018.
- Over 3 years, Exchange Rate Effect stood at -$25000.0 in 2016, then slumped by 548.0% to -$162000.0 in 2017, then soared by 470.37% to $600000.0 in 2018.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $600000.0, -$607000.0, and $218000.0 for Q4 2018, Q3 2018, and Q2 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.33 Bn | 78.34 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.13 Bn | 59.95 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.47 Bn | 55.33 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.04 Bn | 27.73 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.48 Bn | 10.09 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.23 Bn | 26.39 Bn | - | - |
| 10 | SciSparc | 807,202.50 | 807,202.50 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 600,000.00 |
| Dec 31, 2018 | 600,000.00 |
| Sep 30, 2018 | -607,000.00 |
| Sep 30, 2018 | -607,000.00 |
| Jun 30, 2018 | 218,000.00 |
| Jun 30, 2018 | 218,000.00 |
| Mar 31, 2018 | 90,000.00 |
| Mar 31, 2018 | 90,000.00 |
| Dec 31, 2017 | -162,000.00 |
| Dec 31, 2017 | -162,000.00 |
| Sep 30, 2017 | 81,000.00 |
| Sep 30, 2017 | 81,000.00 |
| Jun 30, 2017 | -453,000.00 |
| Jun 30, 2017 | -453,000.00 |
| Mar 31, 2017 | 7,000.00 |
| Mar 31, 2017 | 7,000.00 |
| Dec 31, 2016 | -25,000.00 |
| Dec 31, 2016 | -25,000.00 |
| Sep 30, 2016 | 17,000.00 |
| Sep 30, 2016 | 17,000.00 |